Two-year clinical follow-up of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in The Netherlands (MR CLEAN): design and statistical analysis plan of the extended follow-up study

Autor: van den Berg, LA, Dijkgraaf, MGW, Berkhemer, Olvert, Fransen, Puck, Beumer, D, Lingsma, Hester, Majoie, C B M, Dippel, Diederik, van der Lugt, Aad, van Oostenbrugge, RJ, Zwam, WH, Roos, YBWEM, Invesigators, Mr Clean

Publikováno v: Trials, 17:555. BioMed Central Ltd
Trials
Trials, 17(1). BioMed Central
Trials, 17:555. BioMed Central Ltd.
van den Berg, L A, Dijkgraaf, M G W, Berkhemer, O A, Fransen, P S S, Beumer, D, Lingsma, H F, Majoie, C B L M, Dippel, D W J, van der Lugt, A J, van Oostenbrugge, R J, van Zwam, W H, Roos, Y B W E M & for the MR CLEAN invesigators 2016, ' Two-year clinical follow-up of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in The Netherlands (MR CLEAN) : Design and statistical analysis plan of the extended follow-up study ', Trials, vol. 17, no. 1, 555 . https://doi.org/10.1186/s13063-016-1669-6
Trials, 17(1):555. BioMed Central

MR CLEAN was the first randomized trial to demonstrate the short-term clinical effectiveness of endovascular treatment in patients with acute ischemic stroke caused by large vessel occlusion in the anterior circulation. Several other trials confirmed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5075262474d5f66e56fb805c7ac5fa2e
https://doi.org/10.1186/s13063-016-1669-6